Page 7 - Read Online
P. 7
28 Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma
Andrea Martini, Patrizia Pontisso
Hepatoma Res 2018;4:28 http://dx.doi.org/10.20517/2394-5079.2018.50
29 Understanding the inflammation-cancer transformation in the development of primary liver
cancer
Hong-Jin Chen, Ming-Hua Hu, Fang-Gui Xu, Hao-Jun Xu, Jun-Jun She, Hong-Ping Xia
Hepatoma Res 2018;4:29 http://dx.doi.org/10.20517/2394-5079.2018.18
30 Oncogenic Wnta promising specific biomarker in hepatocellular carcinoma
Min Yao, Miao Fang, Wen-Jie Zheng, Deng-Fu Yao
Hepatoma Res 2018;4:30 http://dx.doi.org/10.20517/2394-5079.2018.32
31 Performance of different biomarkers for the management of hepatocellular carcinoma
Ángela Rojas, Yolanda Sánchez-Torrijos, Antonio Gil-Gómez, Chang-Hai Liu, Clara Rodríguez-Rivas,
María Teresa Ferrer, Manuel Romero-Gómez
Hepatoma Res 2018;4:31 http://dx.doi.org/10.20517/2394-5079.2018.60
32 The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma
Saranya Chidambaranathan-Reghupaty, Rachel Mendoza, Paul B. Fisher, Devanand Sarkar
Hepatoma Res 2018;4:32 http://dx.doi.org/10.20517/2394-5079.2018.34
33 Living donor liver transplantation for patients with hepatocellular carcinoma in Japan
Yasuhiko Sugawara, Hidekazu Yamamoto, Taizo Hibi
Hepatoma Res 2018;4:33 http://dx.doi.org/10.20517/2394-5079.2018.69
34 Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications
Elias Kouroumalis, Demetrius Samonakis, George Notas
Hepatoma Res 2018;4:34 http://dx.doi.org/10.20517/2394-5079.2018.33
35 [ F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular
18
carcinoma model treated with sorafenib
Fernando Gomes de Barros Costa, José Tadeu Stefano, Daniele de Paula Faria, Caio de Souza Levy,
Maria Cristina Chammas, Camila de Godoi Carneiro, Isabel Veloso Alves Pereira, Bruno Cogliati,
Flair José Carrilho, Claudia P. Oliveira
Hepatoma Res 2018;4:35 http://dx.doi.org/10.20517/2394-5079.2018.06
36 Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals
Akshata Moghe, Obaid S. Shaikh
Hepatoma Res 2018;4:36 http://dx.doi.org/10.20517/2394-5079.2018.54
37 Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma
Supriya Sen
Hepatoma Res 2018;4:37 http://dx.doi.org/10.20517/2394-5079.2018.39
